REVB
Revelation Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.01
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-106.8%
Return on equity
-86.0%
Return on assets
-104.3%
Return on invested capital
0.00x
Asset turnover
-$9.3M
Cash from operations
$2.88
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026